795
Participants
Start Date
March 31, 2010
Primary Completion Date
December 31, 2014
Study Completion Date
March 31, 2015
Triflusal
Dose: 150mg or 300mg capsule, 300mg bid, Mode of administration: oral, Duration: from randomization to 31 December 2014
Clopidogrel
Dose: 75mg tablet, 75mg once daily, Mode of administration: oral, Duration: from randomization to 31 December 2014
Department of Neurology, Wonju Christian Hospital, Yonei University Wonju College of Medicine, Wŏnju
Department of Neurology, National Health Insurance Corporation Ilsan Hospital, Goyang-si
Department of Neurology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam-si
Changwon Fatima Hospital, Changwon
Keimyung University Dongsan Medical Center, Daegu
Kyungpook National University Hospital, Daegu
Yeungnam University Hospital, Daegu
Department of Neurology, Konyang University Hospital, Daejeon
Department of Neurology, Chosun University Hospital, Gwangju
Department of Neurology, National Medical Center, Seoul
Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul
KyungHee University Medical Center, Seoul
Department of Neurology, Kyung Hee University Hospital at Gangdong, Seoul
Department of Neurology, Gangnam Severance Hospital, Yonsei Univ. College of Medicine, Seoul
Korea University Anam Hospital, Seoul
Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul
Department of Neurology, Korea University Guro Hospital, Seoul
Department of Neurology, Ewha Womans University Mokdong Hospital, Seoul
Collaborators (1)
Myung In Pharmaceutical Company
UNKNOWN
Yonsei University
OTHER
Gangnam Severance Hospital
OTHER